Amino acid sequence for detecting autoantibody of tumor immune marker BIRC5 and applicaiton
A tumor marker and autoantibody technology, which is applied in the field of preparation of early diagnosis reagents for tumors and the development of targeted drugs for the treatment of tumors, can solve problems such as undetectable, and achieve the effect of high specificity and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] kit preparation
[0037] 1 Reagents See Tab.2-9 for reagent preparation.
[0038] Tab.2 Antigen coating buffer Sodium azide 0.1g PBS (0.01M, pH7.4) 100ml Store at 4°C
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047] 2 operations
[0048] (1) Coating: the working antigen and reference antigen are diluted to the working concentration with coating solution, and coated on the microtiter plate,
[0049] overnight at 4°C.
[0050] (2) Add plasma (primary antibody): Wash the ELISA plate 3 times with washing buffer, dilute the plasma to an appropriate concentration with the analysis solution, generally 1:100-1:500, 100 μl per well, incubate at 25°C or room temperature 2~3h;
[0051] (3) Secondary antibody incubation: wash with washing buffer for 3 to 5 times, dilute the secondary antibody standard solution IgG with the analytical solution, add 200 μl to each well, and incubate at 25°C / room temperatur...
Embodiment 2
[0055] Detection of BIRC5 auto-IgG antibody in patients with lung cancer
[0056] Sample collection: 271 plasma samples of lung cancer patients (including 113 cases of phosphorus carcinoma and 176 cases of adenocarcinoma) and 227 serum samples of age- and sex-matched healthy individuals were collected for lung cancer research. The clinical diagnosis of tumor patients conforms to the International Classification of Diseases standard ICD-10. The healthy group and the lung cancer group were matched in gender and age and were comparable (P>0.05)
[0057] Lung cancer detection results: According to Tab.10, the area under the ROC curve (AUC) of BIRC5 antibody IgG in serum of lung cancer patients is 0.66, the sensitivity is 37.8%, and the specificity is 90.4%; the level of BIRC5 antibody IgG in plasma of patients is significantly higher than that of healthy people group (Z=4.74, P<0.0001). The above data fully show that the autoantibody IgG level of lung cancer patients detected by...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com